# Sanitam Partners LLC — restructuring/exchange_offer [announced]
Source: sec.gov · situation sit_c8c6b0f332e6a56c46d5 · public 5310395786827882160 · retrieved 2026-08-19T12:06:06.356Z

## Overview
Matinas BioPharma Holdings, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.

On July 10, 2026, Matinas BioPharma Holdings, Inc. entered into inducement offer letter agreements with warrant holders, including Sanitam Partners LLC affiliates, whereby holders agreed to exercise outstanding warrants at $0.35 per share for cash in exchange for the issuance of new unregistered common stock purchase warrants (New Warrants). AKSLP exercised warrants to purchase 344,710 shares of Common Stock and received New Warrants to purchase 344,710 shares, while SternAegis DBP exercised warrants to purchase 630,335 shares and received New Warrants to purchase 630,335 shares. The New Warrants will be exercisable at $0.35 per share beginning upon receipt of stockholder approval and will expire five years thereafter, subject to beneficial ownership limitations of 4.99% and 9.99%.

## Terms
- Counterparty: Matinas BioPharma Holdings, Inc. · Consideration: mixed · Price/share: $0.35

## Key dates
- Announced 2026-08-13

## Timeline
- 2026-08-13 · SCHEDULE 13D/A (0000921895-26-002111): SCHEDULE 13D/A - Sanitam Partners LLC — *Matinas BioPharma Holdings, Inc. is a pharmaceutical company engaged in the development and commercialization of pharmaceutical preparations.* On July 10, 2026, Matinas BioPharma Holdings, Inc. entered into inducement offer letter agreements with warrant holders, including Sanitam Partners LLC affiliates, whereby holders agreed to exercise outstanding warrants at $0.35 per share for cash in exchange for the issuance of new unregistered common stock purchase warrants (New Warrants). AKSLP exercised warrants to purchase 344,710 shares of Common Stock and received New Warrants to purchase 344,710 shares, while SternAegis DBP exercised warrants to purchase 630,335 shares and received New Warrants to purchase 630,335 shares. The New Warrants will be exercisable at $0.35 per share beginning upon receipt of stockholder approval and will expire five years thereafter, subject to beneficial ownership limitations of 4.99% and 9.99%.
  https://www.sec.gov/Archives/edgar/data/2056830/0000921895-26-002111.txt

## Citations
- 0000921895-26-002111 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000092189526002111